“…The introduction of functional diversity at the nucleic acid backbone has proven to be of importance for the development of new ligands (aptamers, siRNA; Bramsen, Grünweller, Hartmann, & Kjems, 2014;Ruckman et al, 1998), catalysts (XNAZymes; Taylor & Holliger, 2015), and nanostructures with potential applications as new materials (XNA origami; Taylor et al, 2016). Indeed, XNAs can have physicochemical properties that make them highly relevant to biomedical and biotechnological applications: Higher resistance to nucleases, increased duplex stability (to DNA, RNA, or to the XNA itself), improved pharmacokinetic properties, and reduced immunogenic potential (Bramsen et al, 2014;Pinheiro & Holliger, 2014).…”